Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Universal Health Services, Inc. UHS

Healthcare — Medical Care Facilities
S&P 500 Member Dividend Champion (5y)
Indexes indicate stock being part of an index ,
Growth Flags show if company had growth for consecutive years

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Register an account and get your Powerpack now or Login

Insider Decisions

Total sells
1.20
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell 1 1 — — — 1 — — — — — —
Insider Ownership
18.22%

Capital & Financial Ratios

Market Cap
10,650.00
Revenue
18,114.49
Net Income
1,550.21
Free Cash Flow
845.40
Net Debt
4,713.05
Current Ratio
1.12
Debt/Equity
0.64
P/E ratio
7.12
P/S ratio
0.58
P/B ratio
1.39
Past 5Y EPS Growth
13.00%
This Y EPS Growth
3.63%
Next Y EPS Growth
6.34%
Next 5Y EPS Growth
6.93%
in millions of $

Dividends

Payout Ratio
0.08
Annual Dividend Rate
0.80
Annual Dividend Yield
0.49%
total individual payouts
2028 ‡‡‡‡‡
2027 ‡‡‡‡‡
2026 0.83
—
—
—
2025 0.80
—
—
—
—
2024 0.80
—
—
—
—
2023 0.80
—
—
—
—
2022 0.80
—
—
—
—
2021 0.80
—
—
—
—
2020 0.20
—
2019 0.60
—
—
—
—
2018 0.40
—
—
—
—
2017 0.40
—
—
—
—
2016 0.40
—
—
—
—
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 119.44 125.98 137.80 138.80
Receivables 2,238.27 2,177.75 2,602.43 2,801.11
Inventory 216.99 220.94 232.11 234.09
Other 236.66 291.61 435.57 505.32
2,811.35 2,816.29 3,407.92 3,679.33
2023 2024 2025 Q'26
Payables 613.97 632.00 750.13 2,451.18
ST’ Debt 126.69 40.06 748.16 771.91
Other 5.38 — — —
2,013.35 2,210.41 3,239.60 3,297.66
in millions of $

Compound Annual Growth

10y 5y 3y
Sales ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Book Value ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Mar Jun Sep Dec Year
’26 4,495.18 4,638.01 — —
—
’25 4,099.72 4,283.82 4,495.25 4,486.05
17,364.83
’24 3,843.58 3,907.60 3,963.03 4,113.72
15,827.93
’23 3,467.52 3,548.14 3,562.77 3,703.55
14,281.98
’22 3,292.96 3,323.41 3,336.03 3,446.98
13,399.37
’21 3,012.99 3,197.88 3,156.00 3,275.25
12,642.12
’20 2,829.67 2,729.75 2,912.54 3,086.94
11,558.90
in millions of $

Operating Cash Flow

Mar Jun Sep Dec Year
’26 401.63 443.30 — —
—
’25 360.05 548.98 380.68 574.69
1,864.40
’24 396.41 679.28 332.98 658.44
2,067.10
’23 290.75 362.95 161.67 452.43
1,267.80
’22 445.43 32.61 220.67 297.30
996.02
’21 71.80 47.65 442.23 322.02
883.70
’20 502.06 949.31 766.79 142.01
2,360.17
in millions of $

Free Cash Flow

Mar Jun Sep Dec Year
’26 184.47 215.67 — —
—
’25 121.02 282.96 133.11 312.15
849.25
’24 187.87 437.89 85.05 412.49
1,123.29
’23 122.00 195.04 (38.34) 246.04
524.74
’22 245.43 (175.35) 59.08 132.86
262.02
’21 (175.66) (187.10) 258.41 132.39
28.04
’20 317.96 778.80 574.74 (42.64)
1,628.86
in millions of $

EPS

Mar Jun Sep Dec Year
’26 5.65 5.98 — —
—
’25 4.80 5.43 5.86 7.06
23.10
’24 3.82 4.26 3.80 4.96
16.82
’23 2.28 2.42 2.40 3.16
10.23
’22 2.02 2.20 2.50 2.43
9.14
’21 2.43 3.79 2.60 3.00
11.82
’20 1.64 2.95 2.82 3.60
10.99

Target Price Range

High
‡‡‡‡‡
‡‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡‡

Recommendation Rating

2.4
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ 82.50 113.69 150.11 152.33 — — —
Low Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 158.28 158.57 243.25 246.33 — — —
High Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 93,800 96,700 99,000 101,500 — — —
Employees
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.14 0.15 0.16 0.17 — — —
Revenue/Emp
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 13,399.37 14,281.98 15,827.93 17,364.83 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 89.00% 89.27% 89.97% 90.45% — — —
Gross Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 866.26 940.43 1,497.94 1,972.14 — — —
EBT
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 6.46% 6.58% 9.46% 11.36% ‡‡‡ ‡‡‡ ‡‡‡
EBT Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 656.98 719.31 1,163.11 1,511.18 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Income
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 581.86 568.04 584.83 618.74 — — —
Depreciation
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 183.26 206.03 237.82 273.11 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue/Sh
‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 9.23 10.35 17.16 23.42 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 13.62 18.29 31.06 29.32 ‡‡‡‡ — —
Cash Flow/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (10.04) (10.72) (14.18) (15.97) ‡‡‡ ‡‡‡ ‡‡‡
Capex/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3.58 7.57 16.88 13.36 — — —
Free CF/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 81.59 89.39 101.41 115.42 ‡‡‡‡‡ — —
Book Value/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 73.12 69.32 66.55 63.58 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shares
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 15.43 15.10 10.44 9.29 ‡‡‡‡ ‡‡‡‡ ‡‡‡
PE Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.78 0.76 0.75 0.80 ‡‡‡ ‡‡‡ ‡‡‡
PS Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.75 1.75 1.77 1.89 ‡‡‡ ‡‡‡ ‡‡‡
PB Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.13 1.09 1.03 1.06 ‡‡‡‡ ‡‡‡ ‡‡‡‡
EV/Sales
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 57.75 29.80 14.53 21.76 — — —
EV/FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 996.02 1,267.80 2,067.10 1,864.40 ‡‡‡ ‡‡‡ ‡‡‡
Op' Cash Flow
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (734.00) (743.05) (943.81) (1,015.15) ‡‡‡‡‡ — —
Capex
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 262.02 524.74 1,123.29 849.25 ‡‡‡‡‡ — —
FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 622.92 798.00 605.88 168.31 — — —
Working Cap'
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 4,807.98 4,912.47 4,504.54 4,752.55 — — —
Total Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 4,705.16 4,793.03 4,378.56 4,614.75 — — —
Net Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 5,965.35 6,196.72 6,749.52 7,338.79 — — —
Sh' Equity
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 5.08% 5.23% 8.03% 9.93% — — —
ROA
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 5.88% 6.68% 9.45% 10.43% — — —
ROIC
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 11.10% 11.80% 17.64% 21.14% — — —
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

Universal Health Services (UHS) stands out as a resilient powerhouse in healthcare, delivering a robust 6.2% revenue CAGR from $9.8 billion in 2016 to $15.8 billion in 2024, fueled by surging patient volumes, strategic acquisitions in behavioral health, and pricing power. Post-COVID margin recovery has supercharged profitability, with EPS rocketing 138% to $17.16 and free cash flow per share exploding 123% to $16.88, amplified by aggressive share buybacks slashing outstanding shares by 36%. Projections dazzle: 10% revenue growth in 2025, EPS leaping 51% to $25.93 by 2027, and behavioral health as a massive secular tailwind amid mental health demand.

Trading at an enticing 10.4x 2024 earnings and 0.75x sales—well below historical norms—UHS offers compelling value with a fortress balance sheet, ROE at 17.6%, and net debt at a manageable 2.8x EBITDA. While insider selling and regulatory risks like Medicare cuts warrant watchfulness, the stock’s proximity to consensus targets (with 29% upside potential in high cases) and predictable cash flows scream opportunity for patient investors eyeing mid-single-digit growth and further repurchases.

Dive into the full analysis for deeper dives on efficiency metrics, valuation comps, and why UHS’s operational resilience could unlock even brighter upside in a recovering sector.

Read full commentary →

Universal Health Services, Inc. (UHS) Latest News

News by impact score

Fine-tune

28 Aug

3 , 8:27 AM
Questions arise whether operational resiliency can sustain HCA's long-term profitability amid sector pressures, with potential implications for peers like Universal Health Services. Discussion of resiliency factors may moderately sway investor views on HCA and comparable operators without major strategic shifts.

20 Aug

3 , 12:43 PM
Universal Health Services shares declined 21% year to date, prompting analysis on whether the stock represents a buying opportunity now. Year-to-date share drop signals moderate pressure on near-term investor sentiment and valuation without altering core operations.

18 Aug

3 , 3:49 PM
Universal Health Services (UHS) reported Q2 results as part of hospital chains stock highlights, detailing revenue, earnings and operational metrics for the operator. Q2 financial highlights provide moderate insight into performance without signaling major strategic or competitive changes.

3 , 9:51 AM
Universal Health Services adds Talkspace to accelerate virtual behavioral health growth. Talkspace integration targets virtual behavioral health expansion with moderate effect on UHS operations and growth.

17 Aug

5 www.healthcaredive.com, 4:05 AM
UHS closes $835M acquisition of Talkspace in a deal labeled a game changer. $835M Talkspace purchase marks major strategic expansion into digital mental health.

4 , 8:52 AM
Universal Health Services, Inc. completes acquisition of Talkspace, Inc. Acquisition adds telehealth mental health capabilities to UHS operations and growth profile.

5 Aug

3 , 12:29 AM
Universal Health Services completed its share buyback after Q2 2026 earnings, prompting evaluation of whether the stock is undervalued. Buyback finish and quarterly earnings can shift near-term valuation views and investor flows for UHS.

3 Aug

3 , 1:01 PM
Universal Health Services’s Q2 earnings call featured five analyst questions highlighting company performance, operational challenges, and strategic outlook. Q2 earnings call questions can moderately shape near-term investor views on operations and guidance but rarely alter long-term company trajectory.

29 Jul

3 www.healthcaredive.com, 6:40 AM
UHS reports rising uninsured patient volumes in Q2, signaling potential revenue shortfalls from reduced insurance reimbursements. Rising uninsured volumes point to near-term revenue pressure on core hospital operations.

3 , 1:01 AM
Universal Health Services reported Q2 acute care growth supported by outpatient initiatives that shape its future outlook. Q2 acute care growth and outpatient initiatives produce moderately noticeable effects on UHS financial performance and positioning.

28 Jul

4 , 5:01 PM
Universal Health Services Inc (UHS) achieved strong EPS growth in Q2 2026 earnings call amid ongoing operations. Strong EPS growth from earnings call signals improved financial performance likely to boost stock valuation and investor sentiment.

3 www.marketbeat.com, 5:04 PM
Universal Health Services reported Q2 results with focus on revenue, patient volumes, and operational metrics during its earnings call. Q2 earnings updates and guidance can shift near-term investor sentiment and valuation without altering long-term strategy.

3 , 9:36 AM
Universal Health Services, Inc. reported Q2 earnings and revenue above analyst estimates despite cost pressures. Earnings and revenue beats signal stronger financial results that can shift investor views and near-term stock movement.

3 transcript app.moby.co, 8:30 AM
Universal Health Services, Inc. released Q2 2026 earnings results and forward outlook during its earnings call. Quarterly earnings data and guidance directly shape near-term investor views and trading activity.

27 Jul

4 , 4:16 PM
Universal Health Services, Inc. reports financial results for the three and six months ended June 30, 2026, and revises its 2026 full-year operating results forecast. Earnings release including full-year forecast revision directly shifts investor expectations and valuation.

3 , 6:00 PM
Universal Health Services reported Q2 earnings with analysis of key financial metrics. Quarterly earnings release supplies updated performance data that can shift near-term investor views and valuation.

3 , 5:35 PM
Universal Health Services reported Q2 earnings and revenues that exceeded estimates. Q2 earnings and revenue beats can lift near-term investor sentiment and stock price.

3 , 4:30 PM
Universal Health Services beat Q2 CY2026 sales expectations yet its stock declined after the report. Earnings beat paired with immediate stock drop points to moderate effects on near-term investor sentiment and valuation.

26 Jul

3 , 7:10 AM
UHS secured a US$700 million short-term loan and executed a dividend adjustment that alters its investment profile. Loan and dividend actions modify UHS capital structure and shareholder distributions with moderate financial effects.

25 Jul

3 , 11:57 PM
Universal Health Services (UHS) Q2 earnings expectations center on revenue, patient volumes and guidance that may drive near-term stock moves in the healthcare sector. Q2 earnings forecasts can moderately shift investor views and trading around UHS shares ahead of the actual release.

23 Jul

3 , 12:44 PM
Universal Health Services faces rising Q2 costs that may be offset by acute care segment strength, influencing overall financial results and operational performance. Rising Q2 costs potentially balanced by acute care strength indicate moderate effects on financial performance without major trajectory shifts.

7 Jul

3 , 3:40 AM
Universal Health Services, Inc. (UHS) GW Agreement strengthens its physician-led care delivery model. GW Agreement reinforces UHS physician-led care model potentially improving operational efficiency and market positioning.

4 Jul

4 , 4:08 PM
Universal Health Services (UHS) stock may trade at a discount after Medicare payment news affecting healthcare providers. Medicare payment changes directly reduce UHS revenues and alter investor outlook.

4 , 8:09 AM
Universal Health Services (UHS) shares rose 8.7% after CMS proposed increased hospital payments with analyst backing. CMS payment hike proposal directly lifts UHS revenue outlook and triggers major stock gains.

29 Jun

3 , 4:42 PM
Universal Health Services (NYSE:UHS) outperformed peers in Q1 hospital chain earnings review with standout results. Q1 earnings outperformance can lift near-term sentiment and valuation for UHS.

29 May

3 GlobeNewswire, 9:13 AM
Talkspace stockholders vote to approve acquisition by Universal Health Services, Inc. (UHS). UHS acquisition of Talkspace adds telehealth capabilities to its behavioral health operations.

8 May

3 Zacks, 9:45 AM
Universal Health Services (UHS) emerges as a strong growth stock due to impressive earnings growth, solid Zacks Rank, robust Growth Score, and favorable Value Score amid positive healthcare sector dynamics. Bullish growth stock analysis underscores UHS's financial metrics and industry tailwinds, moderately lifting investor sentiment without transformative changes.

4 May

3 StockStory, 5:00 PM
Universal Health Services' Q1 earnings call featured top five analyst questions on behavioral health volumes, Medicare reimbursement pressures, capital spending plans, acute care recovery trends, and earnings guidance reaffirmation. Analyst questions highlight operational challenges and financial outlook with moderately noticeable influence on UHS market performance.

2 May

4 Simply Wall St., 4:07 PM
Universal Health Services, Inc. (UHS) adds Talkspace to expand its virtual behavioral health reach. UHS's addition of Talkspace represents a major strategic expansion into high-growth virtual behavioral health, likely enhancing revenue streams and competitive positioning.

29 Apr

3 www.healthcaredive.com, 8:18 AM
Universal Health Services, Inc. (UHS) reaffirmed its 2026 volume targets despite seasonal headwinds impacting Q1 results. Reaffirmation of 2026 volume targets despite Q1 seasonal hits bolsters moderate investor confidence in long-term growth trajectory.
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us